Research Interests:
Antibotic resistance, molecular diagnostics, treatment of resistant infections, travel and tropical infections, parasitology .

Recent Publications:

For a list of Dr. Lagacé-Wiens PubMed articles, please click here

1. Lagacé-Wiens PRS, DeCorby MR, Baudry PJ, Hoban DJ, Karlowsky JA, the Canadian Antimicrobial Resistance Alliance (CARA)  and Zhanel GG. Analysis of 1560 in- and out-patient Escherichia coli isolates from across Canada – Results from the CANWARD 2007 study. Can J Infect Dis Med Microbiol. In press.
2. Zhanel GG, DeCorby M, Nichol KA, Wierzbowski A, Baudry PJ, Franil T, Lagacé-Wiens P, Walkty A, Fanella S, Larios O, Mulvey MR, McCracken M, Karlowsky JA, Hoban DJ. Antimicrobial resistant pathogens in Canadian hospitals: Results of the Canadian ward surveillance study (CANWARD 2007). Can J Infect Dis Med Microbiol. In press.
3. Baudry PJ, McCraken M, Lagacé-Wiens P, Mulvey MR, Zhanel GG and Hoban DJ. Prevalence and Characterization of Extended-Spectrum ß-Lactamase-Producing (ESBL) Enterobacteriaceae Isolated in Canadian Hospitals: Results from CANWARD 2007. J Infect Dis Med Microbiol. In press.
4. Baudry PJ, Nichol K, DeCorby M, Lagacé-Wiens P, Olivier E, Boyd D, Mulvey MR, Hoban DJ and Zhanel GG. Mechanisms of Resistance and Mobilization among Multi-Drug Resistant CTX-M-producing Escherichia coli  from Canadian Intensive Care Units. Diagn Microbiol Infect Dis. In Press.
5. Zhanel GG, Decorby M, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, Mulvey MR, Hoban DJ; The Canadian Antimicrobial Resistance Alliance (CARA). Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagn
   Microbiol Infect Dis. 2008. 62:67–80
6. Lagacé-Wiens PRS, DeCorby MR, Baudry PJ, Hoban DJ, Karlowsky JA, the CAN-ICU study group and Zhanel GG. Differences in Antimicrobial Susceptibility in Escherichia coli from Canadian Intensive Care Units Based on Regional and Demographic Variables. Canadian Journal of Infectious Diseases and Medical Microbiology. 2008.19(4):282-6.
7. Zhanel GG, DeCorby M, Nichol KA, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, McCracken M, Mulvey MR, Hoban DJ. Characterization of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli in intensive care units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) study (2005-2006). Canadian Journal of Infectious Diseases and Medical Microbiology. 2008. 19(3):243-9.
8. Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Kim A. Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, McCracken M, Mulvey MR, Johnson J, The Canadian Antimicrobial Resistance Alliance(CARA), and Hoban DJ. Antimicrobial Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005/2006. Antimicrobial Agents and Chemotherapy. 2008. 52(4):1430-7.
9. Lagacé-Wiens PRS, Alfa M, Manickam K, Harding G.  Reduction in Workload and Reporting Time of MRSA Screening with MRSASelect™ Medium versus Mannitol-Salt Medium Supplemented with Oxacillin. Journal of Clinical Microbiology. 2008. 46(4):1174-7.
10. Lagacé-Wiens PRS, Ng B, Reimer A, Burdz T and Bernard K. Gardnerella vaginalis bacteremia in a previously healthy man – Case report and characterization of the isolate. Journal of Clinical Microbiology. 2007. 46:804-6.
11. Zhanel GG, Trapp S, Gin AS, DeCorby M, Lagacé-Wiens PRS, Rubinstein E, Hoban DJ and Karlowsky JA. Dalbavancin and Telavancin: Novel Lipoglycopeptides for the Treatment of Gram-Positive Infections. Expert Review of Anti-Infective Therapy. 2007. 6:67-81.
12. Lagacé-Wiens PRS, Dookeran R, Skinner SJ, Leicht R, Colwell DD, Galloway TD. Human Ophthalmomyiasis Caused by Hypoderma tarandi, Northern Canada. Emerging infectious Diseases. 2007. 14:64-6
13. Al-Hujailan G and Lagacé-Wiens P, Mechanical valve endocarditis caused by Gemella morbillorum. Journal of Medical Microbiology. 56:1689-91.
14. Lagacé-Wiens P, Alfa M, Manickam K, Karlowsky J. Thermostable DNase is Superior to Tube Coagulase for the Direct Detection of Staphylococcus aureus in Positive Blood Cultures. Journal of Clinical Microbiology 45:3478-9.
15. Lagacé-Wiens P, Harding G. Strongyloides stercoralis and HTLV-1 co-infection in a Canadian Immigrant. Canadian Medical Association Journal. 177:451-3.
16. Lagacé-Wiens PRS, Nichol KA, Nicolle LE, DeCorby MR, McCracken M, Alfa MJ. Mulvey MR and Zhanel GG. ESBL genotypes in fluoroquinolone resistant and susceptible Extended Spectrum b-Lactamase (ESBL) Producing
    Escherichia coli Urinary Isolates in Manitoba. Canadian Journal of Infectious Diseases & Medical Microbiology. 2007. 18: 133-8.
17. Lagacé-Wiens P, VanCaeseele P, Koschik C. Dientamoeba fragilis – An emerging intestinal parasite. Canadian Medical Association Journal. 2006. 175 : 468-70.
18. Lagacé-Wiens PRS, Nichol KA, Nicolle LE, DeCorby MR, McCracken M, Alfa MJ, Mulvey MR and Zhanel GG. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-b-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.  Journal of Antimicrobial Chemotherapy. 2006. 57(6):1262-1263.
19. Lagacé-Wiens P, Harding G. A Non-Healing Nodule in a Returned Traveller. Canadian Medical Association Journal. 2006. 174(6):775-6.
20. Lagacé-Wiens P, Rubinstein E. Multidrug Resistant Acinetobacter Infections. Antibiotics for Clinicians. 2005. 9(2):311-315.

PUBLICATIONS (BOOK CHAPTERS)

1. Lagacé-Wiens P, Rubinstein E. Cardiac Aspergillosis. In : Aspergillus (Ed. A.C. Pasqualotto). Springer, Netherlands, 2008.
2. Geiger JD, Lagacé-Wiens P, Bastianetto  S, Quirion R. Creatine and Ginkgo Biloba Use in Sport and Health: A Knowledge Utilization Approach. In : Diet-Brain Connections:  Impact on Memory, Aging and Disease. (Ed. M. Mattson). Kluwer Academic Publishers. 2002